Doxycycline Does Not Influence Established Abdominal Aortic Aneurysms in Angiotensin II-Infused Mice

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Xie, Xiaojie ^a,b   Lu, Hong ^a   Moorleghen, Jessica J ^a   Howatt, Deborah A ^a   Rateri, Debra L ^a   Cassis, Lisa A ^c   Daugherty, Alan ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CHOLESTEROL; DOXYCYCLINE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA RUPTURE; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG TREATMENT FAILURE; ECHOGRAPHY; EX VIVO STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANGIOTENSIN II; ANIMALS; ANTI-BACTERIAL AGENTS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; AORTIC RUPTURE; BLOOD PRESSURE; CHOLESTEROL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DOXYCYCLINE; INFUSION PUMPS, IMPLANTABLE; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, LDL; VASOCONSTRICTOR AGENTS;

MUS;

EID: 84866893810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046411     Document Type: Article

References (42)

1. Powell JT, Sweeting MJ, Brown LC, Gotensparre SM, Fowkes FG, et al. (2011) Systematic review and meta-analysis of growth rates of small abdominal aortic aneurysms. Br J Surg 98: 609-618.
2. Baxter BT, Terrin MC, Dalman RL, (2008) Medical management of small abdominal aortic aneurysms. Circulation 117: 1883-1889.
3. Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, et al. (1996) Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 23: 336-346.
4. Choke E, Cockerill G, Wilson WR, Sayed S, Dawson J, et al. (2005) A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 30: 227-244.
5. Pearce WH, Shively VP, (2006) Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs. Ann NY Acad Sci 1085: 117-132.
6. Newman KM, Jean-Claude J, Li H, Scholes JV, Ogata Y, et al. (1994) Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 20: 814-820.
7. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, et al. (1995) Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15: 1145-1151.
8. Fontaine V, Jacob MP, Houard X, Rossignol P, Plissonnier D, et al. (2002) Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 161: 1701-1710.
9. Wilson WR, Anderton M, Schwalbe EC, Jones JL, Furness PN, et al. (2006) Matrix metalloproteinase-8 and-9 are increased at the site of abdominal aortic aneurysm rupture. Circulation 113: 438-445.
10. Curci JA, Liao SX, Huffman MD, Shapiro SD, Thompson RW, (1998) Expression and localization of macrophage elastase (Matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 102: 1900-1910.
11. Mao D, Lee JK, VanVickle SJ, Thompson RW, (1999) Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. Biochem Biophys Res Commun 261: 904-910.
12. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, et al. (2002) Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110: 625-632.
13. Longo GM, Buda SJ, Fiotta N, Xiong W, Griener T, et al. (2005) MMP-12 has a role in abdominal aortic aneurysms in mice. Surgery 137: 457-462.
14. Xiong W, Knispel R, MacTaggart J, Greiner TC, Weiss SJ, et al. (2009) Membrane-type 1 matrix metalloproteinase regulates macrophage-dependent elastolytic activity and aneurysm formation in vivo. J Biol Chem 284: 1765-1771.
15. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, et al. (2000) Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 105: 1641-1649.
16. Thompson RW, Baxter BT, (1999) MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Ann NY Acad Sci 878: 159-178.
17. Daugherty A, Manning MW, Cassis LA, (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105: 1605-1612.
18. Daugherty A, Cassis LA, (2004) Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 24: 429-434.
19. Prall AK, Longo GM, Mayhan WG, Waltke EA, Fleckten B, et al. (2002) Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg 35: 923-939.
20. Manning MW, Cassis LA, Daugherty A, (2003) Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 23: 483-488.
21. Saraff K, Babamusta F, Cassis LA, Daugherty A, (2003) Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23: 1621-1626.
22. Barisione C, Charnigo R, Howatt DA, Moorleghen JJ, Rateri DL, et al. (2006) Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography. J Vasc Surg 44: 372-376.
23. Daugherty A, Cassis LA, Lu H, (2011) Complex pathologies of angiotensin II-induced abdominal aortic aneurysms. J Zhejiang Univ Sci B 12: 624-628.
24. Rateri DL, Howatt DA, Moorleghen JJ, Charnigo R, Cassis LA, et al. (2011) Prolonged infusion of angiotensin II in apoE-/- mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysms. Am J Pathol 179: 1542-1548.
25. Daugherty A, Cassis L, (1999) Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice. Ann NY Acad Sci 892: 108-118.
26. Daugherty A, Rateri D, Lu H, Balakrishnan A, (2009) Measuring blood pressure in mice using volume pressure recording, a tail-cuff method. J Vis Exp 1291.
27. Daugherty A, Rateri DL, (1994) Presence of LDL receptor-related protein/alpha 2-macroglobulin receptors in macrophages of atherosclerotic lesions from cholesterol- fed New Zealand and heterozygous Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb 14: 2017-2024.
28. Axisa B, Naylor AR, Bell PR, Thompson MM, (2000) Simple and reliable method of doxycycline determination in human plasma and biological tissues. J Chromatogr B Biomed Sci Appl 744: 359-365.
29. Wang YX, Cassis LA, Daugherty A (2006) Angiotensin II-induced abdominal aortic aneurysms. A Handbook of Mouse Models for Cardiovascular Disease Ed. Q. Xu, John Wiley & Sons: 125-136.
30. Lu H, Rateri DL, Daugherty A, (2007) Immunostaining of mouse atherosclerosis lesions. Methods Mol Med 139: 77-94.
31. Petrinec D, Holmes DR, Liao S, Golub LM, Thompson RW, (1996) Suppression of experimental aneurysmal degeneration with chemically modified tetracycline derivatives. Ann NY Acad Sci 800: 263-265.
32. Curci JA, Petrinec D, Liao S, Golub LM, Thompson RW, (1998) Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg 28: 1082-1093.
33. Kaito K, Urayama H, Watanabe G, (2003) Doxycycline treatment in a model of early abdominal aortic aneurysm. Surg Today 33: 426-433.
34. Sho E, Chu J, Sho M, Fernandes B, Judd D, et al. (2004) Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms. J Vasc Surg 39: 1312-1321.
35. Bartoli MA, Parodi FE, Chu J, Pagano MB, Mao D, et al. (2006) Localized administration of doxycycline suppresses aortic dilatation in an experimental mouse model of abdominal aortic aneurysm. Ann Vasc Surg 20: 228-236.
36. Turner GH, Olzinski AR, Bernard RE, Aravindhan K, Karr HW, et al. (2008) In vivo serial assessment of aortic aneurysm formation in apolipoprotein E-deficient mice via MRI. Circ Cardiovasc Imaging 1: 220-226.
37. Lindeman JH, Abdul-Hussien H, van Bockel JH, Wolterbeek R, Kleemann R, (2009) Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation 119: 2209-2216.
38. Uchida HA, Kristo F, Rateri DL, Lu H, Charnigo R, et al. (2010) Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice. Atherosclerosis 211: 399-403.
39. Golledge J, Muller J, Daugherty A, Norman P, (2006) Abdominal aortic aneurysm. Pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 26: 2605-2613.
40. Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, et al. (2005) Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 11: 1330-1338.
41. Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, et al. (2001) Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: A randomized, double-blind, placebo-controlled pilot study. J Vasc Surg 34: 606-610.
42. Baxter BT, Pearce WH, Waltke EA, Littooy FN, Hallett JW Jr, et al. (2002) Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg 36: 1-12.